The SLC20A2 gene is closely associated with Primary Familial Brain Calcification (PFBC), also known as Basal Ganglia Calcification Type 1. This condition is characterized by the accumulation of calcium deposits in the brain, particularly in the basal ganglia, which can lead to a variety of neurological symptoms including movement disorders, psychiatric symptoms, and cognitive impairment. The condition is hereditary, following an autosomal dominant pattern of inheritance, meaning a single copy of the altered gene in each cell is sufficient to cause the disorder.
The genetic test for identifying mutations in the SLC20A2 gene is crucial for diagnosing PFBC. It helps in confirming the diagnosis, understanding the risk of transmission to offspring, and aiding in the management and treatment of the condition. This test involves analyzing the DNA to look for mutations in the SLC20A2 gene that are known to cause the condition.
In the UAE, DNA Labs offers this specialized genetic test. The cost of the test is set at 4400 AED. DNA Labs UAE is equipped with advanced genetic testing facilities to provide accurate and reliable results. The test is performed under the guidance of genetic experts and is aimed at individuals who have a family history of PFBC or exhibit symptoms suggestive of basal ganglia calcification.
By opting for this test, individuals can gain valuable insights into their genetic makeup, enabling them and their healthcare providers to make informed decisions regarding their health and management of the condition.
The "PDGFRB Gene Basal Ganglia Calcification Type 4 Genetic Test" is a specialized diagnostic tool designed to detect mutations in the PDGFRB gene, which are implicated in Basal Ganglia Calcification Type 4, also known as Primary Familial Brain Calcification (PFBC) Type 4. This condition is characterized by the accumulation of calcium deposits in the basal ganglia, a critical part of the brain involved in regulating movement, which can lead to a range of neurological symptoms including movement disorders, psychiatric symptoms, and cognitive impairment.
The test is particularly valuable for individuals who have a family history of PFBC or who exhibit symptoms suggestive of basal ganglia calcification. Early detection through genetic testing can aid in the diagnosis, management, and understanding of the condition, potentially guiding treatment options and genetic counseling.
Performed at DNA Labs UAE, a reputable genetic testing facility, the test cost is set at 4400 AED. DNA Labs UAE employs state-of-the-art genetic sequencing technologies to ensure accurate and reliable results, providing crucial information for affected individuals and their families. This genetic test represents a critical step towards personalized medicine in the management of PFBC Type 4, offering hope and clarity for those affected by this rare condition.
The PDGFB Gene Basal Ganglia Calcification Type 5 Idiopathic Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the PDGFB gene, which are linked to Primary Familial Brain Calcification (PFBC), also known as Idiopathic Basal Ganglia Calcification Type 5. PFBC is a rare neurological disorder characterized by the accumulation of calcium deposits in the basal ganglia and other brain regions, leading to a range of neurological symptoms including movement disorders, psychiatric symptoms, and cognitive deterioration.
This genetic test plays a crucial role in the accurate diagnosis of the condition, enabling targeted management and counseling for affected individuals and their families. By analyzing the specific genetic makeup of the PDGFB gene, healthcare professionals can confirm the diagnosis of PFBC, differentiate it from other neurological conditions with similar presentations, and understand the inheritance pattern within a family.
The test is priced at 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify mutations in the PDGFB gene. Conducted at DNA Labs UAE, a facility known for its state-of-the-art genetic testing services, patients and healthcare providers can expect reliable and comprehensive results. This genetic test is an essential resource for those seeking answers to complex neurological conditions, providing a foundation for personalized treatment plans and familial risk assessment.
The "XPR1 Gene Basal Ganglia Calcification Type 6 Idiopathic Genetic Test" is a specialized diagnostic assessment available at DNA Labs UAE. Priced at 4400 AED, this test is designed to identify mutations in the XPR1 gene, which are associated with Basal Ganglia Calcification Type 6, a rare neurological disorder. The condition is characterized by the accumulation of calcium deposits in the basal ganglia, regions of the brain that control movement, and can lead to a variety of symptoms including movement disorders, psychiatric symptoms, and cognitive impairment. As an idiopathic form, the cause of the calcification is unknown, making genetic testing a critical tool for diagnosis. The test provides crucial information for affected individuals and their families regarding prognosis, treatment options, and the risk of passing the condition to future generations, making it an invaluable resource in the management of this rare condition.
The UPB1 gene beta-ureidopropionase deficiency genetic test is a specialized diagnostic procedure offered by DNA Labs UAE, aimed at detecting mutations in the UPB1 gene, which can lead to beta-ureidopropionase deficiency. This rare genetic disorder disrupts the normal breakdown of nucleic acids, leading to various neurological and physical symptoms, including developmental delay, seizures, and skin problems. The test is crucial for early diagnosis and management of the condition, enabling tailored treatment plans that can significantly improve the quality of life for affected individuals. The cost of the test is 4400 AED, reflecting the comprehensive analysis and expertise required to accurately identify the presence of genetic mutations associated with this condition.
The FREM1 gene plays a crucial role in embryonic development, including the formation of facial structures. Mutations in the FREM1 gene can lead to a rare congenital condition known as bifid nose, characterized by a nose divided into two parts due to a developmental anomaly. To diagnose this condition, DNA Labs UAE offers a specialized genetic test focused on identifying mutations in the FREM1 gene that are associated with a bifid nose. This test is crucial for accurate diagnosis and understanding the genetic basis of the condition, which can aid in management and counseling. The cost of the FREM1 Gene Bifid Nose Genetic Test at DNA Labs UAE is 4400 AED. This test is a valuable tool for individuals seeking answers about this rare genetic condition, providing them with crucial information for medical and personal decision-making.
The FLCN Gene Birt-Hogg-Dubé Syndrome Genetic Test is a specialized diagnostic examination offered by DNA Labs UAE, aimed at identifying mutations in the FLCN gene, which are indicative of Birt-Hogg-Dubé (BHD) Syndrome. BHD Syndrome is a rare genetic condition characterized by skin lesions, lung cysts, and an increased risk of kidney tumors. The test plays a crucial role in the early detection and management of the syndrome, allowing for timely intervention and monitoring for associated complications.
This genetic test involves analyzing the patient's DNA to look for specific mutations in the FLCN gene that are known to cause BHD Syndrome. It is usually recommended for individuals with a family history of the condition or those exhibiting symptoms related to BHD Syndrome.
The cost of the FLCN Gene Birt-Hogg-Dubé Syndrome Genetic Test at DNA Labs UAE is 4400 AED. This price reflects the comprehensive nature of the test, covering the genetic analysis, professional interpretation of the results, and follow-up consultations to discuss the findings. Given the specialized nature of the test and its importance in the diagnosis and management of BHD Syndrome, the investment is considered valuable for those at risk of this genetic condition.
The BCS1L Gene Bjornstad Syndrome Genetic Test is a specialized diagnostic assessment offered by DNA Labs UAE, designed to identify mutations in the BCS1L gene, which are responsible for Bjornstad Syndrome. This condition is characterized by the combination of sensorineural hearing loss and pili torti (twisted hair), and it may present other symptoms depending on the severity of the genetic mutation. The test plays a critical role in confirming the diagnosis, enabling early intervention and management of the condition. Conducted in the advanced facilities of DNA Labs UAE, the test costs 4400 AED and provides a comprehensive analysis, ensuring accurate results for affected individuals and their families. Through this genetic testing, healthcare providers can offer targeted treatment plans and counseling, significantly improving the quality of life for those with Bjornstad Syndrome.
The NOD2 Gene Blau Syndrome Genetic Test is a specialized diagnostic assessment offered by DNA Labs UAE, designed to identify mutations in the NOD2 gene, which are linked to Blau syndrome. Blau syndrome is a rare genetic condition characterized by a triad of symptoms: granulomatous arthritis, uveitis, and dermatitis. This autosomal dominant disorder necessitates early and accurate diagnosis to manage symptoms and prevent severe complications effectively.
DNA Labs UAE, leveraging advanced genetic testing technologies, provides this test at a cost of 4400 AED. The test involves collecting a DNA sample from the patient, typically through a blood draw or cheek swab, which is then analyzed in the laboratory to detect the presence of specific mutations in the NOD2 gene that are associated with Blau syndrome. This precise genetic testing allows for a definitive diagnosis, enabling tailored treatment plans and genetic counseling for affected individuals and their families.
The ASXL1 gene Bohring-Opitz Syndrome genetic test is a specialized diagnostic tool designed to identify mutations in the ASXL1 gene, which are linked to Bohring-Opitz Syndrome (BOS). This rare genetic disorder is characterized by distinctive facial features, growth delays, intellectual disability, and various physical abnormalities. Early detection through this test can aid in the management and treatment of the condition.
Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test employs advanced genomic technologies to analyze the ASXL1 gene for any alterations that might indicate the presence of BOS. The process involves collecting a DNA sample, usually through a blood draw or cheek swab, which is then meticulously examined for specific genetic mutations associated with the syndrome.
The cost of the ASXL1 gene Bohring-Opitz Syndrome genetic test at DNA Labs UAE is 4400 AED. This price reflects the comprehensive nature of the test, encompassing the sophisticated analysis and the expertise required to interpret the results accurately. Given the complexity of genetic disorders like BOS, having access to such precise diagnostic tools is invaluable for affected families, offering insights into potential treatment paths and helping to manage the condition more effectively.
